PsyRx is a drug development company developing GMP-standard naturally sourced psychedelics including psilocybin and ibogaine.
PsyRx
PsyRx is focusing its attention on manufacturing pharmaceutical-grade psychedelics. The company is aiming to supply pharmaceutical companies with naturally produced psilocybin and ibogaine that can be administered to patients in microdoses in order to help alleviate symptoms of depression without the intense psychological effects of higher doses.
“Natural pharmaceutical-grade psychedelics for a new generation of mental health therapeutics”
Activities
B2B
Manufacturing
Biotech
Compounds of Interest
Ibogaine
Psilocybin
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates